References
- Barbier L, Jamal W, Dokmak S, et al. Impact of total pancreatectomy: short- and long-term assessment. HPB (Oxford). 2013;15:882–892.
- ReMine WH, Priestley JT, Judd ES, et al. Total pancreatectomy. Ann Surg. 1970;172:595–604.
- Schmidt CM, Glant J, Winter JM, et al. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery. 2007;142:572–578.
- Janot MS, Belyaev O, Kersting S, et al. Indications and early outcomes for total pancreatectomy at a high-volume pancreas center. HPB Surg. 2010;2010. doi: 10.1155/2010/686702.
- Murphy MM, Knaus WJ, 2nd, Ng SC, et al. Total pancreatectomy: a national study. HPB (Oxford). 2009;11:476–482.
- Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009;250:282–287.
- Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011;149:79–86.
- Kulu Y, Schmied BM, Werner J, et al. Total pancreatectomy for pancreatic cancer: indications and operative technique. HPB (Oxford). 2009;11:469–475.
- Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg. 2007;11:209–216.
- Müller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatectomy? Ann Surg. 2007;246:966–974.
- Pliam MB, ReMine WH. Further evaluation of total pancreatectomy. Arch Surg. 1975;110:506–512.
- Dresler CM, Fortner JG, McDermott K, et al. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131–140.
- Tamborlane WV, Sherwin RS, Genel M, et al. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573–578.
- Launois B, Franci J, Bardaxoglou E, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg. 1993;17:122–126.
- Ihse I, Anderson H, Andren-Sandberg A. Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg. 1996;20:288–294.
- Sarr MG, Behrns KE, van Heerden JA. Total pancreatectomy. An objective analysis of its use in pancreatic cancer. Hepatogastroenterology. 1993;40:418–421.
- Sugiyama M, Atomi Y. Pylorus-preserving total pancreatectomy for pancreatic cancer. World J Surg. 2000;24:66–71.
- Karpoff HM, Klimstra DS, Brennan MF, et al. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg. 2001;136:44–47.
- Bhayani NH, Miller JL, Ortenzi G, et al. Perioperative outcomes of pancreaticoduodenectomy compared to total pancreatectomy for neoplasia. J Gastrointest Surg. 2014;18:549–554.
- Ito T, Doi R, Yoshizawa A, et al. The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Sci. 2011;18:241–246.
- Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:326–233.
- Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg. 2005;9:1059–1066.
- Hartwig W, Gluth A, Hinz U, et al. Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg. 2015;261:537–546.
- Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Investig. 2010;1:212–228.
- Yamaguchi K, Konomi H, Kobayashi K, et al. Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy. Hepatogastroenterology. 2005;52:1585–1590.
- Sohn TA, Campbell KA, Pitt HA, et al. Quality of life and long-term survival after surgery for chronic pancreatitis. J Gastrointest Surg. 2000;4:364–365.
- Casadei R, Ricci C, Monari F, et al. Clinical outcome of patients who underwent total pancreatectomy. Pancreas. 2010;39:546–547.
- Stauffer JA, Nguyen JH, Heckman MG, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11:483–492.
- Epelboym I, Winner M, DiNorcia J, et al. Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. J Surg Res. 2014;187:189–196.
- Datta J, Lewis RS Jr, Strasberg SM, et al. Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective. J Gastrointest Surg. 2015;19:506–515.
- Jethwa P, Sodergren M, Lala A, et al. Diabetic control after total pancreatectomy. Dig Liver Dis. 2006;38:415–419.
- Parsaik AK, Murad MH, Sathananthan A, et al. Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf). 2010;73:723–731.
- Watanabe Y, Ohtsuka T, Matsunaga T, et al. Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life. World J Surg. 2015;39:1231–1239.
- Jamil LH, Chindris AM, Gill KR, et al. Glycemic control after total pancreatectomy for intraductal papillary mucinous neoplasm: an exploratory study. HPB Surg. 2012;2012. doi:10.1155/2012/381328.
- McCullagh EP, Cook JR, Shirey EK. Diabetes following total pancreatectomy; clinical observations of ten cases. Diabetes. 1958;7:298–307.
- Nosadini R, del Prato S, Tiengo A, et al. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982;31:346–355.
- Barnes AJ, Bloom A, Crowley MF, et al. Is glucagon important in stable insulin-dependent diabetics? Lancet. 1975;2:734–737.
- Kiviluoto T, Schröder T, Karonen SL, et al. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res. 1985;17:110–115.
- Del Prato S, Tiengo A, Baccaglini U, et al. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia. 1983;25:252–259.
- Bellin MD, Kerdsirichairat T Beilman GJ, et al. Total pancreatectomy with islet autotransplantation improves quality of life in patients with refractory recurrent acute pancreatitis. Clin Gastroenterol Hepatol. 2016;16:S1542–S3565.
- Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409–424.
- Chinnakotla S, Radosevich DM, Dunn TB, et al. Long-term outcomes of total pancreatectomy and islet auto transplantation for hereditary/genetic pancreatitis. J Am Coll Surg. 2014;218:530–543.
- Muratore S, Zeng X, Korc M, et al. Metastatic pancreatic adenocarcinoma after total pancreatectomy islet autotransplantation for chronic pancreatitis. Am J Transplant. 2016. [Epub ahead of print]. doi: 10.1111/ajt.13851.
- Tanaka N, Horiuchi A, Yokoyama T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758–768.
- Kato H, Isaji S, Azumi Y, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296–304.
- Murata Y, Mizuno S, Kato H, et al. Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection. Clin J Gastroenterol. 2011;4:242–248.
- Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol. 2010;105:2276–2286.
- Kishi Y, Shimada K, Nara S, et al. Administration of pancrelipase as effective treatment for hepatic steatosis after pancreatectomy. Pancreas. 2015;44:983–987.
- Hata T, Ishida M, Motoi F, et al. Clinical characteristics and risk factors for the development of postoperative hepatic steatosis after total pancreatectomy. Pancreas. 2016;45:362–369.
- Belyaev O, Herzog T, Chromik AM, et al. Early and late postoperative changes in the quality of life after pancreatic surgery. Langenbecks Arch Surg. 2013;398:547–555.